Code |
MEDS |
Title |
PT Hetzer Medical Indonesia Tbk |
Address |
|
Background |
The Companys current business activites is trade and industry of masks and medical equipment. |
Business cp product |
The Companys current business activites is trade and industry of masks and medical equipment. |
Subsidiary affiliation |
|
Commissioners |
President Commissioner | : Jemmy Kurniawan | | Commissioner | : Franciscus Rijadi | | Independent Commissioner | : Tato Suprapto Basir | | | | | Per 30 Sep 2023 | | |
|
Directors |
President Director | : A. Padmono Budi Sanyoto | | Director | : Herry | | Director | : Fancy Marsiana, S.H. | | | | | Per 30 Sep 2023 | | |
|
Underwriter |
|
Share registrar |
|
Share holders |
Shareholders | Shares | % | | | Jemmy Kurniawan | 562500000 | 36 | | | Franciscus Rijadi | 437500000 | 28 | | | A. Padmono Budi Sanyoto | 62500000 | 4 | | | Fancy Marsiana, S.H. | 62500000 | 4 | | | Herry | 1716100 | 0.11 | | | Public | 435783900 | 27.89 | | | | | | | | As of Sep 30, 2023 | | | | |
|
History stocks |
Type of ListingDatePrice## of SharesTotal Listed Shares IPO @ Rp 12510-Aug-2022203125000001562500000
|
Other infos |
|
Created date |
2023-11-14 14:19:53 |
Revised date |
2023-11-14 14:19:53 |
Finance |
PT Hetzer Medical Indonesia Tbk |
Financial Statetment Date |
Fiscal Year Ends |
Months Covered in Income St |
|
Summary Covered in Income St |
Cash and Cash Equivalents |
Receivables |
Inventories |
Current Assets |
Fixed Assets |
Other Assets |
Non Current Assets |
Total Assets |
Current Liabilities |
Longterm Liabilities |
Total Liabilities |
Authorized |
Paid-up Capital |
Par Value |
Paid-up Capital Shares |
Retained Earnings |
Total Equity |
Minority Interest |
|
Summary of Income Statement |
Total Sales |
Cost of Good Sold |
Gross Profit |
Operating Profit |
Other Income |
Earning Before Tax |
Tax |
Net Income |
Close Price |
|
Per Share Data (Rp) |
Eps (annualized) |
Book Value |
|
Financial Ratios |
Debt Equity Ratio (X) |
Roa(%) |
Roe(%) |
Npm(%) |
Opm(%) |
Gross Profit Margin (%) |
Total Assets Turnover |
|
Cash Flow |
CF from Operation Activities |
CF from Investing Activities |
CF from Financing Activities |
Net Increase in Cash & Cash Equivalent |
Cash & Cash Equivalent at Beginning of the Year |
Cash & Cash Equivalent at The End of the Year |
|
|